Boasting a technology that can dramatically increase the capacity of existing polymerase chain reaction (PCR) testing used to identify people infected with COVID-19 and other illnesses, ChromaCode has attracted new funding from Bill Gates-backed Adjuvant Capital.
“We want a good solution for a resource-limited environment,” says ChromaCode founder and executive chairman Alex Dickinson, a serial entrepreneur who has worked with Caltech researchers spinning out companies since the early 2000s.
The technology was based on research conducted by California Institute of Technology graduate student Aditya Rajagopal. A former researcher at Google[x] working on novel medical imaging methods, Rajagopal is the inventor
Read more Source: techcrunch.com